Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thalidomide”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Testing effectiveness (Phase 2)Looking for participantsNCT06279351
What this trial is testing

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer

Who this might be right for
Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Xinqiao Hospital of Chongqing 96
Testing effectiveness (Phase 2)Ended earlyNCT00953615
What this trial is testing

Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)

Who this might be right for
Primary Sclerosing Cholangitis
Mayo Clinic 1
Testing effectiveness (Phase 2)Study completedNCT00320476
What this trial is testing

VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates

Who this might be right for
Multiple Myeloma
Korean Multiple Myeloma Working Party 35
Testing effectiveness (Phase 2)Ended earlyNCT00014443
What this trial is testing

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Rush University Medical Center 5
Post-approval studies (Phase 4)Study completedNCT01664975
What this trial is testing

Treatment of Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Mingzhi Zhang 100
Testing effectiveness (Phase 2)UnknownNCT03204019
What this trial is testing

Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Pancreatic Neuroendocrine Tumor
Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT00193102
What this trial is testing

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 40
Testing effectiveness (Phase 2)Study completedNCT00003894
What this trial is testing

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Who this might be right for
Graft Versus Host DiseaseUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Roswell Park Cancer Institute 36
Large-scale testing (Phase 3)Ended earlyNCT00644306
What this trial is testing

Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma

Who this might be right for
Newly Diagnosed, Multiple Myeloma
Central Hospital, Nancy, France 232
Testing effectiveness (Phase 2)Study completedNCT00142116
What this trial is testing

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's MacroglobulinemiaLymphoplasmacytic Lymphoma
Steven P. Treon, MD, PhD 25
Large-scale testing (Phase 3)Study completedNCT00057564
What this trial is testing

Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene Corporation 470
Testing effectiveness (Phase 2)UnknownNCT00026416
What this trial is testing

Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma

Who this might be right for
Sarcoma
Herbert Irving Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00033332
What this trial is testing

Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00008242
What this trial is testing

Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT01937442
What this trial is testing

Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 7
Testing effectiveness (Phase 2)UnknownNCT00006200
What this trial is testing

Thalidomide and Dacarbazine for Metastatic Melanoma

Who this might be right for
Melanoma
National Center for Research Resources (NCRR)
Large-scale testing (Phase 3)Study completedNCT05132270
What this trial is testing

Clinical Experience of Thalidomide in Thalassemic Patients

Who this might be right for
Thalassemia, Beta
Children's Hospital Karachi 135
Testing effectiveness (Phase 2)UnknownNCT00438841
What this trial is testing

Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT02410694
What this trial is testing

Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Arbeitsgemeinschaft medikamentoese Tumortherapie 90
Large-scale testing (Phase 3)Study completedNCT00083915
What this trial is testing

DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation

Who this might be right for
Multiple Myeloma
University of Arkansas 97
Load More Results